What is Novanta Inc.'s earnings per share (EPS)?

Novanta Inc. (NOVT) reported diluted earnings per share of $1.47 for fiscal year 2025. This represents a -16.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Novanta Inc. (NOVT) Financials

NOVT

Trailing 12 months to July 3, 2026

Revenue $1.0B +7.6% YoY

Net Income $61.8M +0.7% YoY

EPS (Diluted) $1.57 -7.1% YoY

Free Cash Flow $114.3M -3.0% YoY

Market Cap $5.5B as of Oct 13, 2026

Price / Sales 5.3x on $1.0B revenue, trailing 12 months to July 3, 2026

Price / Earnings 89.1x on $61.8M net income, trailing 12 months to July 3, 2026

Price / Book 3.4x on $1.6B equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 13, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jul 3, 2026 Reported Aug 5, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NOVT SEC filings page.

Novanta Inc. (NOVT) reported $1.0B in revenue over the twelve months to Jul 3, 2026, up 7.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI NOVT FY2025 2026-10-04

Revenue is still expanding, but FY2025 shows a business with weaker profit conversion, heavier working-capital needs, and a much less leveraged balance sheet.

FY2025 revenue growth did not translate into operating leverage: operating margin fell to 9.6% from 11.7% in FY2024. Operating cash flow then fell from $158.5M to $64.1M while SG&A rose, indicating that weaker earnings and higher overhead both pressured cash conversion.

The balance sheet is materially less debt-dependent: debt-to-equity compressed from 0.6x in FY2024 to 0.2x in FY2025. With assets expanding while liabilities fell, growth was not accompanied by proportionate borrowing, improving the company’s financial flexibility.

The weaker cash result appears tied partly to working capital absorption: inventory and receivables both rose in FY2025, while free cash flow margin fell from 14.9% to 4.9%. Capital expenditures declined, so reduced cash generation reflects money absorbed elsewhere in operations more than a heavier reinvestment program.

Financial Health Signals

Financial Health Score 72/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Novanta Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Novanta Inc. has an operating margin of 9.6%, meaning the company retains $10 of operating profit per $100 of revenue. This strong profitability earns a score of 73/100, reflecting efficient cost management and pricing power. This is down from 11.7% the prior year.

Growth

Novanta Inc.'s revenue grew a modest 3.3% year-over-year to $980.6M. This slow but positive growth earns a score of 52/100.

Leverage

Novanta Inc. carries a low D/E ratio of 0.16, meaning only $0.16 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 96/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

With a current ratio of 3.69, Novanta Inc. holds $3.69 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 85/100.

Cash Flow

Novanta Inc. has a free cash flow margin of 4.9%, earning a moderate score of 64/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Novanta Inc.'s ROE of 4.1% shows moderate profitability relative to equity, earning a score of 64/100. This is down from 8.6% the prior year.

Altman Z-Score Safe

8.04

Novanta Inc. scores 8.04, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($5.5B) relative to total liabilities ($492.8M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

6/9

Novanta Inc. passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, all 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.19x

For every $1 of reported earnings, Novanta Inc. generates $1.19 in operating cash flow ($64.1M OCF vs $53.8M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

4.38x

Novanta Inc. earns $4.38 in operating income for every $1 of interest expense ($94.0M vs $21.5M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$265.8M

YoY+7.3%

QoQ+3.1%

5Y CAGR+13.2%

10Y CAGR+10.9%

Novanta Inc. generated $265.8M in revenue in Q3 2026. This represents an increase of 7.3% from the same quarter a year earlier. Against the prior quarter it is up 3.1%.

EBITDA

$32.7M

YoY-12.9%

QoQ-21.6%

5Y CAGR+8.8%

10Y CAGR+12.4%

Novanta Inc.'s EBITDA was $32.7M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 12.9% from the same quarter a year earlier. Against the prior quarter it is down 21.6%.

Net Income

$12.5M

YoY+17.7%

QoQ-40.6%

5Y CAGR+8.7%

10Y CAGR+13.8%

Novanta Inc. reported $12.5M in net income in Q3 2026. This represents an increase of 17.7% from the same quarter a year earlier. Against the prior quarter it is down 40.6%.

EPS (Diluted)

$0.30

YoY0.0%

QoQ-41.2%

5Y CAGR+5.5%

10Y CAGR+11.6%

Novanta Inc. earned $0.30 per diluted share (EPS) in Q3 2026. That is unchanged from the same quarter a year earlier. Against the prior quarter it is down 41.2%.

Cash & Balance Sheet

Free Cash Flow

$57.5M

YoY+1264.4%

QoQ+21.1%

5Y CAGR+7.7%

10Y CAGR+27.4%

Novanta Inc. generated $57.5M in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 1264.4% from the same quarter a year earlier. Against the prior quarter it is up 21.1%.

Cash & Debt

$718.6M

YoY+705.5%

QoQ+84.8%

5Y CAGR+46.5%

10Y CAGR+31.2%

Novanta Inc. held $718.6M in cash against $188.2M in long-term debt as of Q3 2026.

Shares Outstanding

38M

YoY+5.7%

QoQ+6.2%

5Y CAGR+1.5%

10Y CAGR+0.9%

Novanta Inc. had 38M shares outstanding in Q3 2026. This represents an increase of 5.7% from the same quarter a year earlier. Against the prior quarter it is up 6.2%.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin

45.5%

YoY+0.7pp

QoQ+1.4pp

5Y change+4.1pp

10Y change+3.2pp

Novanta Inc.'s gross margin was 45.5% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.4 percentage points.

Operating Margin

6.8%

YoY-2.0pp

QoQ-3.9pp

5Y change-1.5pp

10Y change+1.1pp

Novanta Inc.'s operating margin was 6.8% in Q3 2026, reflecting core business profitability. This is down 2.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.9 percentage points.

Net Margin

4.7%

YoY+0.4pp

QoQ-3.5pp

5Y change-1.1pp

10Y change+1.1pp

Novanta Inc.'s net profit margin was 4.7% in Q3 2026, showing the share of revenue converted to profit. This is up 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.5 percentage points.

Return on Equity

0.8%

YoY-0.5pp

QoQ-0.8pp

5Y change-1.1pp

10Y change-0.8pp

Novanta Inc.'s ROE was 0.8% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is down 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.8 percentage points.

Capital Allocation

R&D Spending

$24.0M

YoY-0.5%

QoQ+3.1%

5Y CAGR+9.5%

10Y CAGR+11.3%

Novanta Inc. invested $24.0M in research and development in Q3 2026. This represents a decrease of 0.5% from the same quarter a year earlier. Against the prior quarter it is up 3.1%.

Share Buybacks

YoY-100.0%

QoQ-100.0%

Novanta Inc. repurchased no shares in Q3 2026. This represents a decrease of 100.0% from the same quarter a year earlier. Against the prior quarter it is down 100.0%.

Capital Expenditures

$7.5M

YoY+74.3%

QoQ+80.4%

5Y CAGR+24.2%

10Y CAGR+22.9%

Novanta Inc. invested $7.5M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 74.3% from the same quarter a year earlier. Against the prior quarter it is up 80.4%.

NOVT Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NOVT quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$1.0B	$980.6M+3.3%	$949.2M+7.7%	$881.7M+2.4%	$860.9M+21.8%	$706.8M+19.7%	$590.6M-5.7%	$626.1M+1.9%	$614.3M+17.8%	$521.3M+35.5%	$384.8M+3.0%	$373.6M+2.4%	$364.7M+15.1%	$316.9M+30.0%	$243.8M-19.9%	$304.3M
Cost of Revenue	$571.0M	$545.3M+3.3%	$527.7M+9.5%	$481.8M-0.1%	$482.4M+18.7%	$406.5M+17.4%	$346.1M-4.9%	$364.0M+3.2%	$352.8M+17.3%	$300.8M+35.3%	$222.3M+3.1%	$215.7M+0.5%	$214.5M+16.2%	$184.7M+33.6%	$138.3M-19.2%	$171.2M
Gross Profit	$458.7M	$435.3M+3.3%	$421.5M+5.4%	$399.9M+5.7%	$378.5M+26.0%	$300.3M+22.8%	$244.5M-6.7%	$262.1M+0.2%	$261.5M+18.6%	$220.5M+35.8%	$162.5M+2.9%	$157.9M+5.1%	$150.2M+13.6%	$132.2M+25.3%	$105.5M-20.7%	$133.1M
R&D Expenses	$94.2M	$95.5M0.0%	$95.5M+4.2%	$91.7M+6.9%	$85.8M+18.3%	$72.5M+18.9%	$61.0M+9.0%	$56.0M+9.7%	$51.0M+22.4%	$41.7M+30.2%	$32.0M+3.1%	$31.0M+7.2%	$29.0M+21.7%	$23.8M+28.4%	$18.5M-21.0%	$23.5M
SG&A Expenses	$217.3M	$195.7M+11.2%	$175.9M+7.0%	$164.5M+3.5%	$158.9M+23.0%	$129.2M+17.6%	$109.9M-7.2%	$118.4M+2.2%	$115.9M+14.0%	$101.7M+25.0%	$81.3M-0.9%	$82.0M-2.8%	$84.4M+10.5%	$76.3M+27.9%	$59.7M-12.0%	$67.9M
Operating Income	$92.3M	$94.0M-15.0%	$110.6M+0.1%	$110.5M+7.2%	$103.1M+60.9%	$64.1M+14.6%	$55.9M+1.1%	$55.3M-22.2%	$71.0M+23.4%	$57.6M+74.7%	$33.0M+13.9%	$28.9M+272.2%	-$16.8M-186.4%	$19.4M-4.0%	$20.3M-43.5%	$35.8M
EBITDA	N/A	$155.9M-6.1%	$166.1M+5.8%	$157.1M+0.6%	$156.2M+45.4%	$107.4M+14.1%	$94.2M+0.7%	$93.6M-13.4%	$108.1M+22.4%	$88.3M+63.8%	$53.9M+9.8%	$49.1M+545.2%	$7.6M-80.7%	$39.4M+16.1%	$33.9M-33.6%	$51.1M
Interest Expense	$13.0M	$21.5M-31.8%	$31.5M+22.0%	$25.8M+65.3%	$15.6M+111.4%	$7.4M+12.5%	$6.6M-22.7%	$8.5M-13.5%	$9.8M+37.0%	$7.2M+57.2%	$4.6M+188.0%	-$5.2M-1.6%	-$5.1M-46.9%	-$3.5M-24.2%	-$2.8M-121.4%	$13.1M
Income Tax	$17.9M	$15.8M+5.6%	$15.0M+37.8%	$10.9M-17.1%	$13.1M+124.4%	$5.8M+50.5%	$3.9M-22.3%	$5.0M-51.1%	$10.2M-26.2%	$13.8M+31.4%	$10.5M+1.2%	$10.4M+1133.2%	-$1.0M-116.2%	$6.2M+153.5%	-$11.6M-555.8%	$2.5M
Net Income	$61.8M	$53.8M-16.0%	$64.1M-12.1%	$72.9M-1.6%	$74.1M+47.1%	$50.3M+13.1%	$44.5M+9.2%	$40.8M-17.0%	$49.1M-18.2%	$60.1M+172.9%	$22.0M-38.2%	$35.6M+246.9%	-$24.3M-431.8%	$7.3M-62.6%	$19.5M-32.6%	$29.0M
EPS (Basic)	N/A	$1.47-17.4%	$1.78-12.3%	$2.03-2.4%	$2.08+46.5%	$1.42+11.8%	$1.27+9.5%	$1.16-20.5%	$1.46+28.1%	$1.14+81.0%	$0.63-38.8%	$1.03+247.1%	-$0.70-433.3%	$0.21-63.8%	$0.58-33.3%	$0.87
EPS (Diluted)	$1.57	$1.47-16.9%	$1.77-12.4%	$2.02-1.9%	$2.06+46.1%	$1.41+12.8%	$1.25+8.7%	$1.15-19.6%	$1.43	$1.13	$0.63-38.2%	$1.02+245.7%	-$0.70-433.3%	$0.21-63.8%	$0.58-32.6%	$0.86
Diluted Shares (Avg)	N/A	37M+1.6%	36M+0.3%	36M+0.3%	36M+0.4%	36M+0.4%	36M+0.3%	36M+0.2%	35M	35M	35M+0.2%	35M+1.4%	34M-0.1%	34M+1.4%	34M+1.0%	34M

Metric	Q3'2610-Q	Q2'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$265.8M+7.3%	$257.7M+6.9%	$258.3M+8.5%	$247.8M+1.4%	$241.0M+2.2%	$233.4M+1.1%	$238.1M+12.5%	$244.4M+10.3%
Cost of Revenue	$144.9M+5.8%	$144.1M+7.3%	$145.1M+11.7%	$136.9M+1.3%	$134.3M+1.6%	$129.0M-1.1%	$129.8M+12.9%	$135.2M+12.7%
Gross Profit	$120.9M+9.0%	$113.6M+6.4%	$113.3M+4.7%	$110.9M+1.6%	$106.7M+2.9%	$104.4M+3.9%	$108.2M+12.1%	$109.2M+7.5%
R&D Expenses	$24.0M-0.5%	$23.3M-8.1%	$22.9M-9.6%	$24.1M+3.6%	$25.3M+6.6%	$23.2M0.0%	$25.3M+7.8%	$23.3M+5.6%
SG&A Expenses	$60.0M+16.7%	$54.4M+15.5%	$51.6M+19.1%	$51.4M+15.9%	$47.1M+5.2%	$45.6M+4.7%	$43.3M+3.8%	$44.3M+11.8%
Operating Income	$18.1M-17.3%	$27.5M+84.7%	$24.8M-7.0%	$21.8M-32.9%	$14.9M-42.0%	$32.4M+26.6%	$26.7M+23.2%	$32.6M+7.4%
EBITDA	$32.7M-12.9%	$41.7M+36.8%	$41.9M+2.0%	$37.6M-19.6%	$30.5M-23.4%	$46.0M+19.3%	$41.1M+23.6%	$46.7M+12.0%
Interest Expense	$1.1M-81.6%	$1.8M-68.3%	$4.0M-42.0%	$6.0M-25.6%	$5.8M-29.7%	$5.6M-31.6%	$6.9M+16.4%	$8.1M+19.6%
Income Tax	$3.4M-34.2%	$5.3M+306.7%	$4.2M-2.9%	$5.1M+1.4%	$1.3M-61.7%	$5.2M+132.6%	$4.3M+33.9%	$5.0M+184.2%
Net Income	$12.5M+17.7%	$21.1M+369.2%	$17.5M+6.1%	$10.7M-44.5%	$4.5M-67.3%	$21.2M+44.5%	$16.5M+31.6%	$19.2M-9.6%
EPS (Basic)	$0.31+3.3%	$0.52+333.3%	$0.46+2.2%	$0.30-43.4%	$0.12-68.4%	$0.59+43.9%	$0.45+28.6%	$0.53-10.2%
EPS (Diluted)	$0.300.0%	$0.51+325.0%	$0.46+2.2%	$0.30-43.4%	$0.12-68.4%	$0.59+43.9%	$0.45+32.4%	$0.53-10.2%
Diluted Shares (Avg)	41M+14.2%	41M+14.1%	N/A	36M-0.2%	36M0.0%	36M0.0%	N/A	36M+0.2%

NOVT Balance Sheet

NOVT quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$1.8B+30.1%	$1.4B+13.3%	$1.2B-1.2%	$1.2B+1.1%	$1.2B+41.9%	$865.2M-0.5%	$869.7M+20.9%	$719.6M-1.0%	$726.7M+70.7%	$425.6M+2.3%	$416.0M+5.0%	$396.3M+4.6%	$378.8M+12.3%	$337.5M-3.2%	$348.5M
Current Assets	$782.6M+80.5%	$433.6M+4.4%	$415.3M-1.2%	$420.5M+12.5%	$373.8M+22.9%	$304.2M-0.1%	$304.5M+8.1%	$281.8M-2.1%	$287.9M+44.5%	$199.3M+7.6%	$185.2M+1.1%	$183.2M-9.2%	$201.6M-3.3%	$208.5M-2.7%	$214.3M
Cash & Equivalents	$380.9M+234.1%	$114.0M+8.5%	$105.1M+4.9%	$100.1M-14.7%	$117.4M-6.1%	$125.1M+58.4%	$78.9M-3.8%	$82.0M-18.0%	$100.1M+46.9%	$68.1M+13.6%	$60.0M+17.2%	$51.1M-16.1%	$61.0M-7.3%	$65.8M+20.0%	$54.8M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$188.3M+30.2%	$144.6M-3.2%	$149.4M-11.1%	$168.0M+33.7%	$125.7M+35.5%	$92.7M-20.5%	$116.6M+11.3%	$104.8M+14.8%	$91.3M+52.8%	$59.7M+0.3%	$59.6M-5.4%	$62.9M+8.0%	$58.3M+10.4%	$52.8M+2.4%	$51.5M
Accounts Receivable	$184.9M+22.4%	$151.0M+8.3%	$139.4M+1.2%	$137.7M+19.1%	$115.6M+54.0%	$75.1M-17.6%	$91.1M+8.5%	$84.0M+3.0%	$81.5M+27.8%	$63.8M+11.5%	$57.2M+11.1%	$51.5M+6.1%	$48.6M+13.8%	$42.7M+9.8%	$38.8M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$647.3M+10.8%	$584.1M+20.6%	$484.5M+1.2%	$478.9M-0.1%	$479.5M+67.7%	$286.0M+4.1%	$274.7M+26.2%	$217.7M+3.2%	$211.0M+95.1%	$108.1M+4.5%	$103.5M+14.0%	$90.7M+27.5%	$71.2M+59.6%	$44.6M0.0%	$44.6M
Total Liabilities	$492.8M-23.3%	$642.8M+16.3%	$552.6M-16.7%	$663.6M-6.1%	$706.6M+81.9%	$388.4M-14.2%	$452.6M+28.8%	$351.3M-4.6%	$368.2M+120.8%	$166.8M-2.7%	$171.3M-7.4%	$185.0M+35.7%	$136.4M+24.9%	$109.3M-21.5%	$139.1M
Current Liabilities	$212.4M+26.6%	$167.8M+20.6%	$139.2M-15.4%	$164.5M-10.6%	$183.9M+61.0%	$114.2M-15.3%	$134.8M+29.4%	$104.2M+6.1%	$98.2M+39.3%	$70.5M+23.8%	$57.0M+5.4%	$54.1M-12.1%	$61.5M+11.9%	$54.9M-7.0%	$59.1M
Non-Current Liabilities	$280.5M-41.0%	$475.0M+14.9%	$413.4M-17.2%	$499.1M-4.5%	$522.7M+90.7%	$274.1M-13.7%	$317.7M+28.6%	$247.1M-8.5%	$270.1M+180.5%	$96.3M-15.8%	$114.4M-12.7%	$131.0M+74.8%	$74.9M+37.9%	$54.3M-32.9%	$80.9M
Long-Term Debt	$212.5M-48.4%	$411.9M+17.9%	$349.4M-18.9%	$430.7M+0.3%	$429.4M+120.3%	$194.9M-9.5%	$215.3M+6.2%	$202.8M-10.0%	$225.5M+219.6%	$70.6M-20.2%	$88.4M-15.8%	$105.0M+64.1%	$64.0M+50.6%	$42.5M-26.7%	$58.0M
Total Equity	$1.3B+76.2%	$745.7M+10.7%	$673.5M+16.6%	$577.6M+10.8%	$521.3M+9.3%	$476.8M+14.3%	$417.2M+13.3%	$368.3M+18.2%	$311.5M+20.3%	$258.9M+5.8%	$244.7M+16.1%	$210.8M-12.9%	$242.0M+6.2%	$227.8M+9.0%	$209.0M
Retained Earnings	$321.4M+20.1%	$267.5M+31.5%	$203.5M+55.8%	$130.6M+131.0%	$56.5M+811.5%	$6.2M+116.2%	-$38.3M+51.6%	-$79.1M+38.1%	-$127.7M+23.8%	-$167.5M+11.6%	-$189.6M+15.8%	-$225.2M-12.1%	-$200.9M+3.5%	-$208.2M+8.6%	-$227.8M

Metric	Q3'2610-Q	Q2'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$2.1B+42.1%	$1.8B+19.1%	$1.8B+30.1%	$1.5B+6.1%	$1.5B+8.0%	$1.4B-1.8%	$1.4B+13.3%	$1.4B+18.8%
Current Assets	$1.1B+139.9%	$786.8M+70.3%	$782.6M+80.5%	$468.4M+7.2%	$462.1M+8.8%	$434.1M+1.2%	$433.6M+4.4%	$436.9M+11.7%
Cash & Equivalents	$718.6M+705.5%	$388.8M+253.7%	$380.9M+234.1%	$89.2M-3.7%	$109.9M+11.6%	$106.0M+13.4%	$114.0M+8.5%	$92.7M+22.0%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$192.7M+7.1%	$193.1M+14.9%	$188.3M+30.2%	$180.0M+16.9%	$168.1M+5.0%	$145.4M-9.9%	$144.6M-3.2%	$154.0M+0.1%
Accounts Receivable	$178.7M+4.8%	$173.9M+7.9%	$184.9M+22.4%	$170.6M+3.7%	$161.2M+11.2%	$164.2M+8.8%	$151.0M+8.3%	$164.5M+15.0%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$642.4M-0.8%	$643.4M-0.9%	$647.3M+10.8%	$647.5M+9.0%	$649.1M+10.6%	$589.1M-0.1%	$584.1M+20.6%	$594.1M+24.4%
Total Liabilities	$523.1M-25.7%	$488.0M-31.2%	$492.8M-23.3%	$704.3M+4.1%	$709.6M+1.9%	$615.7M-15.5%	$642.8M+16.3%	$676.6M+23.2%
Current Liabilities	$245.9M+31.6%	$220.8M+21.4%	$212.4M+26.6%	$186.9M+19.3%	$181.9M+18.5%	$169.6M+12.0%	$167.8M+20.6%	$156.6M+13.2%
Non-Current Liabilities	$277.2M-46.4%	$267.2M-49.4%	$280.5M-41.0%	$517.5M-0.5%	$527.7M-2.8%	$446.1M-22.7%	$475.0M+14.9%	$520.0M+26.5%
Long-Term Debt	$188.2M-57.8%	$201.0M-55.7%	$212.5M-48.4%	$445.7M-1.5%	$454.0M-4.8%	$385.3M-24.3%	$411.9M+17.9%	$452.5M+30.1%
Total Equity	$1.6B+101.7%	$1.3B+63.6%	$1.3B+76.2%	$801.5M+8.0%	$801.4M+14.2%	$769.8M+12.9%	$745.7M+10.7%	$742.2M+15.1%
Retained Earnings	$355.0M+16.8%	$342.5M+16.8%	$321.4M+20.1%	$303.9M+21.0%	$293.3M+26.5%	$288.8M+32.4%	$267.5M+31.5%	$251.1M+31.5%

NOVT Cash Flow Statement

NOVT quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$133.8M	$64.1M-59.6%	$158.5M+32.0%	$120.1M+32.3%	$90.8M-4.1%	$94.6M-32.5%	$140.2M+121.7%	$63.2M-29.4%	$89.6M+41.4%	$63.4M+32.6%	$47.8M+43.0%	$33.4M-21.0%	$42.3M-14.0%	$49.2M+73.1%	$28.4M-37.1%	$45.2M
Depreciation & Amortization	N/A	$61.9M+11.5%	$55.6M+19.2%	$46.6M-12.3%	$53.2M+22.5%	$43.4M+13.3%	$38.3M0.0%	$38.3M+3.3%	$37.1M+20.5%	$30.8M+46.7%	$21.0M+3.8%	$20.2M-17.3%	$24.4M+22.4%	$19.9M+45.9%	$13.7M-10.4%	$15.3M
Stock-Based Compensation	N/A	$29.5M+26.7%	$23.3M-8.9%	$25.6M+10.7%	$23.1M-9.8%	$25.6M+10.8%	$23.1M+147.5%	$9.3M+21.1%	$7.7M+40.4%	$5.5M+28.0%	$4.3M-2.1%	$4.4M+1.3%	$4.3M-20.5%	$5.4M+20.0%	$4.5M+38.4%	$3.3M
Capital Expenditures	$19.6M	$15.6M-8.9%	$17.2M-14.0%	$20.0M+1.6%	$19.6M-1.7%	$20.0M+89.8%	$10.5M-2.0%	$10.7M-26.7%	$14.7M+61.2%	$9.1M+7.5%	$8.5M+52.4%	$5.6M+2.5%	$5.4M+13.4%	$4.8M+35.7%	$3.5M-16.5%	$4.2M
Free Cash Flow	$114.3M	$48.4M-65.7%	$141.3M+41.2%	$100.1M+40.7%	$71.1M-4.7%	$74.6M-42.5%	$129.7M+147.1%	$52.5M-30.0%	$75.0M+38.1%	$54.3M+38.0%	$39.3M+41.1%	$27.9M-24.4%	$36.9M-17.0%	$44.4M+78.3%	$24.9M-39.2%	$41.0M
Investing Cash Flow	-$20.3M	-$74.3M+64.3%	-$208.2M-946.6%	-$19.9M+53.2%	-$42.5M+86.1%	-$306.7M-2231.3%	-$13.2M+79.4%	-$63.8M-40.0%	-$45.6M+74.3%	-$177.4M-1278.8%	-$12.9M-687.8%	-$1.6M+98.2%	-$89.8M-23.1%	-$73.0M-2552.3%	$3.0M+170.5%	-$4.2M
Financing Cash Flow	$494.7M	$276.3M+385.3%	$56.9M+158.2%	-$97.9M-62.7%	-$60.2M-129.4%	$204.8M+342.7%	-$84.4M-2043.8%	-$3.9M+93.5%	-$60.2M-142.0%	$143.3M+718.1%	-$23.2M-7.7%	-$21.5M-153.5%	$40.3M+116.9%	$18.6M+188.0%	-$21.1M+51.0%	-$43.1M
Share Buybacks	$51.8M	$39.3M	N/A	N/A	$10.0M	N/A	$5.5M-45.0%	$10.0M+70.9%	$5.8M+1481.1%	$370K-77.4%	$1.6M+0.4%	$1.6M+225.4%	$500K-4.9%	$526K	N/A	N/A

Metric	Q3'2610-Q	Q2'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$64.9M+664.4%	$51.6M+242.4%	$8.8M-85.7%	$8.5M-63.1%	$15.1M-63.3%	$31.7M-3.5%	$61.6M+57.9%	$23.0M-48.4%
Depreciation & Amortization	$14.6M-6.8%	$14.2M-9.1%	$17.1M+18.9%	$15.7M+11.0%	$15.6M+10.4%	$13.6M+4.9%	$14.4M+24.4%	$14.2M+24.2%
Stock-Based Compensation	$9.8M+46.8%	$9.8M+30.6%	N/A	$6.7M+5.2%	$7.5M+20.3%	$7.1M+16.8%	N/A	$6.4M+5.4%
Capital Expenditures	$7.5M+74.3%	$4.1M+22.1%	$3.7M+63.3%	$4.3M+20.3%	$3.4M-31.4%	$4.3M-33.2%	$2.2M-63.8%	$3.6M-47.6%
Free Cash Flow	$57.5M+1264.4%	$47.5M+306.3%	$5.1M-91.3%	$4.2M-78.4%	$11.7M-67.7%	$27.4M+3.7%	$59.3M+81.0%	$19.5M-48.6%
Investing Cash Flow	-$7.5M-38.3%	-$3.8M+94.3%	-$3.6M-74.0%	-$5.4M-51.7%	-$66.6M-1248.2%	$1.3M+100.6%	-$2.1M+66.2%	-$3.6M+47.6%
Financing Cash Flow	$270.6M+1255.4%	-$40.1M-173.2%	$287.6M+907.6%	-$23.4M+18.9%	$54.8M+271.2%	-$42.7M-127.8%	-$35.6M-602.5%	-$28.9M+44.4%
Share Buybacks	$0-100.0%	$18.6M	$19.1M	$14.1M	$0	$6.2M	N/A	N/A

Not reported in any period shown, so not listed: Dividends Paid.

NOVT Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NOVT quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	44.4%0.0pp	44.4%-1.0pp	45.4%+1.4pp	44.0%+1.5pp	42.5%+1.1pp	41.4%-0.5pp	41.9%-0.7pp	42.6%+0.3pp	42.3%+0.1pp	42.2%0.0pp	42.3%+1.1pp	41.2%-0.6pp	41.7%-1.6pp	43.3%-0.5pp	43.7%
Operating Margin	9.6%-2.1pp	11.7%-0.9pp	12.5%+0.6pp	12.0%+2.9pp	9.1%-0.4pp	9.5%+0.6pp	8.8%-2.7pp	11.6%+0.5pp	11.0%+2.5pp	8.6%+0.8pp	7.7%+12.3pp	-4.6%-10.8pp	6.1%-2.2pp	8.3%-3.5pp	11.8%
Net Margin	5.5%-1.3pp	6.8%-1.5pp	8.3%-0.3pp	8.6%+1.5pp	7.1%-0.4pp	7.5%+1.0pp	6.5%-1.5pp	8.0%-3.5pp	11.5%+5.8pp	5.7%-3.8pp	9.5%+16.2pp	-6.7%-9.0pp	2.3%-5.7pp	8.0%-1.5pp	9.5%
Return on Equity	4.1%-4.5pp	8.6%-2.2pp	10.8%-2.0pp	12.8%+3.2pp	9.7%+0.3pp	9.3%-0.4pp	9.8%-3.6pp	13.3%-5.9pp	19.3%+10.8pp	8.5%-6.0pp	14.5%+26.1pp	-11.5%-14.5pp	3.0%-5.6pp	8.6%-5.3pp	13.9%
Return on Assets	3.0%-1.6pp	4.6%-1.3pp	5.9%0.0pp	6.0%+1.9pp	4.1%-1.0pp	5.1%+0.5pp	4.7%-2.1pp	6.8%-1.4pp	8.3%+3.1pp	5.2%-3.4pp	8.6%+14.7pp	-6.1%-8.1pp	1.9%-3.9pp	5.8%-2.5pp	8.3%
Current Ratio	3.69+1.1x	2.58-0.4x	2.98+0.4x	2.56+0.5x	2.03-0.6x	2.66+0.4x	2.26-0.4x	2.70-0.2x	2.93+0.1x	2.83-0.4x	3.25-0.1x	3.39+0.1x	3.28-0.5x	3.80+0.2x	3.63
Debt-to-Equity	0.16-0.4x	0.550.0x	0.52-0.2x	0.75-0.1x	0.82+0.4x	0.41-0.1x	0.520.0x	0.55-0.2x	0.72+0.5x	0.27-0.1x	0.36-0.1x	0.50+0.2x	0.26+0.1x	0.19-0.1x	0.28
Asset Turnover	0.54-0.1x	0.680.0x	0.720.0x	0.69+0.1x	0.58-0.1x	0.680.0x	0.72-0.1x	0.85+0.1x	0.72-0.2x	0.900.0x	0.900.0x	0.92+0.1x	0.84+0.1x	0.72-0.2x	0.87
FCF Margin	4.9%-10.0pp	14.9%+3.5pp	11.4%+3.1pp	8.3%-2.3pp	10.6%-11.4pp	22.0%+13.6pp	8.4%-3.8pp	12.2%+1.8pp	10.4%+0.2pp	10.2%+2.8pp	7.5%-2.6pp	10.1%-3.9pp	14.0%+3.8pp	10.2%-3.2pp	13.5%

Metric	Q3'2610-Q	Q2'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	45.5%+0.7pp	44.1%-0.2pp	43.8%-1.6pp	44.8%+0.1pp	44.3%+0.3pp	44.7%+1.2pp	45.5%-0.2pp	44.7%-1.2pp
Operating Margin	6.8%-2.0pp	10.7%+4.5pp	9.6%-1.6pp	8.8%-4.5pp	6.2%-4.7pp	13.9%+2.8pp	11.2%+1.0pp	13.3%-0.4pp
Net Margin	4.7%+0.4pp	8.2%+6.3pp	6.8%-0.2pp	4.3%-3.6pp	1.9%-4.0pp	9.1%+2.7pp	6.9%+1.0pp	7.8%-1.7pp
Return on Equity	0.8%-0.5pp	1.6%+1.0pp	1.3%-0.9pp	1.3%-1.3pp	0.6%-1.4pp	2.8%+0.6pp	2.2%+0.4pp	2.6%-0.7pp
Return on Assets	0.6%-0.1pp	1.2%+0.9pp	1.0%-0.2pp	0.7%-0.6pp	0.3%-0.7pp	1.5%+0.5pp	1.2%+0.2pp	1.4%-0.4pp
Current Ratio	4.57+2.1x	3.56+1.0x	3.69+1.1x	2.51-0.3x	2.54-0.2x	2.56-0.3x	2.58-0.4x	2.790.0x
Debt-to-Equity	0.12-0.4x	0.15-0.4x	0.16-0.4x	0.56-0.1x	0.57-0.1x	0.50-0.2x	0.550.0x	0.61+0.1x
Asset Turnover	0.120.0x	0.140.0x	0.140.0x	0.160.0x	0.160.0x	0.170.0x	0.170.0x	0.170.0x
FCF Margin	21.6%+19.9pp	18.4%+13.6pp	2.0%-22.9pp	1.7%-6.3pp	4.9%-10.5pp	11.7%+0.3pp	24.9%+9.4pp	8.0%-9.1pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Novanta Inc. NOVT	FY2025	$980.6M	$53.8M	5.5%	$5.5B	72/100
Sensata Technologies Holding plc ST	FY2025	$3.7B	$31.3M	0.8%	$6.2B	45/100
ESCO Technologies, Inc. ESE	FY2025	$1.1B	$299.2M	27.3%	$6.7B	69/100
Vontier Corporation VNT	FY2025	$3.1B	$406.1M	13.2%	$4.4B	57/100
Badger Meter, Inc. BMI	FY2025	$916.7M	$141.6M	15.4%	$3.8B	80/100
Itron Inc ITRI	FY2025	$2.4B	$301.1M	12.7%	$3.7B	63/100

Where Novanta Inc. Ranks

Frequently Asked Questions

What is Novanta Inc.'s annual revenue?

Novanta Inc. (NOVT) reported $980.6M in total revenue for fiscal year 2025. This represents a 3.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Novanta Inc.'s revenue growing?

Novanta Inc. (NOVT) revenue grew by 3.3% year-over-year, from $949.2M to $980.6M in fiscal year 2025.

Is Novanta Inc. profitable?

Yes, Novanta Inc. (NOVT) reported a net income of $53.8M in fiscal year 2025, with a net profit margin of 5.5%.

What is Novanta Inc.'s EBITDA?

Novanta Inc. (NOVT) had EBITDA of $155.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Novanta Inc. have?

As of fiscal year 2025, Novanta Inc. (NOVT) had $380.9M in cash and equivalents against $212.5M in long-term debt.

What is Novanta Inc.'s gross margin?

Novanta Inc. (NOVT) had a gross margin of 44.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Novanta Inc.'s operating margin?

Novanta Inc. (NOVT) had an operating margin of 9.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Novanta Inc.'s net profit margin?

Novanta Inc. (NOVT) had a net profit margin of 5.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Novanta Inc.'s return on equity (ROE)?

Novanta Inc. (NOVT) has a return on equity of 4.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Novanta Inc.'s free cash flow?

Novanta Inc. (NOVT) generated $48.4M in free cash flow during fiscal year 2025. This represents a -65.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Novanta Inc.'s operating cash flow?

Novanta Inc. (NOVT) generated $64.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Novanta Inc.'s total assets?

Novanta Inc. (NOVT) had $1.8B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Novanta Inc.'s capital expenditures?

Novanta Inc. (NOVT) invested $15.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Novanta Inc. spend on research and development?

Novanta Inc. (NOVT) invested $95.5M in research and development during fiscal year 2025.

Does Novanta Inc. buy back shares?

Yes, Novanta Inc. (NOVT) spent $39.3M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Novanta Inc. have outstanding?

Novanta Inc. (NOVT) had 36M shares outstanding as of fiscal year 2025.

What is Novanta Inc.'s current ratio?

Novanta Inc. (NOVT) had a current ratio of 3.69 as of fiscal year 2025, which is generally considered healthy.

What is Novanta Inc.'s debt-to-equity ratio?

Novanta Inc. (NOVT) had a debt-to-equity ratio of 0.16 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Novanta Inc.'s return on assets (ROA)?

Novanta Inc. (NOVT) had a return on assets of 3.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Novanta Inc.'s P/E ratio?

Novanta Inc. (NOVT) trades at 89.1x earnings, its market capitalization divided by net income of $61.8M net income, trailing 12 months to July 3, 2026. The market capitalization is $5.5B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Novanta Inc.'s price-to-sales ratio?

Novanta Inc. (NOVT) trades at 5.3x sales, its market capitalization divided by revenue of $1.0B revenue, trailing 12 months to July 3, 2026. The market capitalization is $5.5B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Novanta Inc.'s Altman Z-Score?

Novanta Inc. (NOVT) has an Altman Z-Score of 8.04, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Novanta Inc.'s Piotroski F-Score?

Novanta Inc. (NOVT) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Novanta Inc.'s earnings high quality?

Novanta Inc. (NOVT) has an earnings quality ratio of 1.19x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Novanta Inc. cover its interest payments?

Novanta Inc. (NOVT) has an interest coverage ratio of 4.38x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Novanta Inc.?

Novanta Inc. (NOVT) scores 72 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.